ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 130 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,637,781 | -18.0% | 4,724,405 | +0.0% | 0.00% | – |
| Q1 2024 | $19,078,989 | +36.0% | 4,722,522 | +2.7% | 0.00% | – |
| Q4 2023 | $14,029,115 | +2.3% | 4,599,710 | +0.6% | 0.00% | – |
| Q3 2023 | $13,720,320 | -18.8% | 4,573,440 | +1.2% | 0.00% | – |
| Q2 2023 | $16,895,820 | +9.9% | 4,517,599 | -1.5% | 0.00% | – |
| Q1 2023 | $15,367,057 | -47.5% | 4,587,181 | -24.7% | 0.00% | -100.0% |
| Q4 2022 | $29,290,601 | -32.1% | 6,089,522 | -19.7% | 0.00% | 0.0% |
| Q3 2022 | $43,155,000 | -15.3% | 7,584,256 | +5.6% | 0.00% | 0.0% |
| Q2 2022 | $50,980,000 | +4.9% | 7,180,285 | +6.7% | 0.00% | 0.0% |
| Q1 2022 | $48,584,000 | -6.0% | 6,729,203 | +16.4% | 0.00% | 0.0% |
| Q4 2021 | $51,690,000 | -71.5% | 5,781,882 | +11.6% | 0.00% | -80.0% |
| Q3 2021 | $181,608,000 | +86.4% | 5,179,955 | +14.2% | 0.01% | +150.0% |
| Q2 2021 | $97,437,000 | +42.6% | 4,536,163 | +309.8% | 0.00% | 0.0% |
| Q1 2021 | $68,351,000 | +50.8% | 1,106,905 | +2.1% | 0.00% | +100.0% |
| Q4 2020 | $45,312,000 | – | 1,084,527 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 5,462,079 | $16,659,341 | 12.62% |
| TANG CAPITAL MANAGEMENT LLC | 4,076,741 | $12,434,060 | 1.15% |
| Stonepine Capital Management, LLC | 839,514 | $2,560,518 | 1.11% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,581,196 | 0.73% |
| CM Management, LLC | 270,000 | $823,500 | 0.66% |
| EcoR1 Capital, LLC | 6,995,861 | $21,337,376 | 0.55% |
| Acuitas Investments, LLC | 171,098 | $615,373 | 0.32% |
| Newtyn Management, LLC | 508,474 | $1,550,846 | 0.30% |
| Diametric Capital, LP | 161,524 | $492,648 | 0.30% |
| Auour Investments LLC | 177,000 | $670,830 | 0.26% |